Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 1, 2016

View Archived Issues

University of Cape Town researchers identify new antimalarial candidate

Starpharma and AstraZeneca enter drug delivery program collaboration

First patient treated in International Stem Cell's phase I study of ISC-hpNSC stem cell therapy

Bristol-Myers Squibb reviews pipeline highlights of second quarter 2016

Preclinical characterization of M1 allosteric modulator SUVN-I4035 in AD models

Boehringer Ingelheim patents sodium channel blockers

Constellation Pharmaceuticals and Genentech report demethylase 2B inhibitors

Merck & Co. discloses BTK inhibitors

Chengdu Bestchiralbio introduces LDL-receptor expression enhancers

Phase II ECOSPOR study of microbiome therapeutic SER-109 fails to meet primary endpoint

Amgen highlights key events of second quarter 2016

Shire's SHP-626 awarded FDA fast track designation

Merck & Co.'s Zepatier receives marketing authorization in Europe

Sunovion Pharmaceuticals submits NDA for SUN-101/eFlow for COPD

Edge Therapeutics announces treatment of first patient in NEWTON 2 study of EG-1962

EMA accepts for review MAA for sarilumab

Taiho seeks approval of additional indications for Zosyn in Japan

Diamyd Medical signs agreement regarding ongoing GABA/GAD trial

Researchers develop software tool that could facilitate and advance drug development

Increased p-cresyl sulfate level is independent predictor of poor outcome in heart failure

NxGEN MDx and NX Prenatal collaborate on the development of a test to identify preterm birth risk

Setmelanotide as potential novel treatment of proopiomelanocortin deficiency

FDA issues complete response letter for ADMA Biologics' BLA for RI-002

PAF receptor activity could mediate aberrant connectivity in epileptogenesis

GSK and Verily to establish a new bioelectronic medicines company

Therapeutic potential of targeting ADAM33 in asthma

FDA approves Dysport for the treatment of lower limb spasticity in children

Chi-Med and AstraZeneca amend savolitinib codevelopment agreement

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...